Author Topic: Escalation vs. early intensive DMT in patients w/MS  (Read 7 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8187
  • MS diagnosed 1980
  • Location: Pacific Northwest
Escalation vs. early intensive DMT in patients w/MS
« on: February 18, 2019, 09:06:15 pm »

From JAMA Neurology (February 18, 2019), "Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis":


https://jamanetwork.com/journals/jamaneurology/fullarticle/2724324?guestAccessKey=cb68f9ab-b5e9-4e4f-a011-fd73e82755f7&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamaneurology&utm_content=olf&utm_term=021819
MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
33 Views
Last post February 23, 2018, 06:51:33 pm
by agate
1 Replies
39 Views
Last post April 26, 2018, 04:27:50 pm
by agate
0 Replies
20 Views
Last post June 24, 2018, 04:12:03 pm
by agate
2 Replies
51 Views
Last post October 05, 2018, 07:33:41 pm
by agate
0 Replies
8 Views
Last post May 13, 2019, 09:57:12 pm
by agate